Colorectal cancer survivors: an investigation of symptom burden and influencing factors

Abstract

BackgroundColorectal cancer is a significant issue internationally, with over 1.3 million people diagnosed annually. Survival rates are increasing as treatments improve, although physical symptoms can persist despite eradication of the tumour. In order to optimize survivorship care, further research is warranted in relation to symptom burden. Therefore, the objectives of this study are to (i) investigate frequency of physical symptoms in colorectal cancer survivors (ii) identify which symptoms occur together (iii) examine the associations between demographic and clinical variables, and symptoms.MethodsParticipants nine months to three years post diagnosis were identified from the population-based National Cancer Registry Ireland. Respondents completed the EORTC QLQ-C30 and EORTC QLQ-CR29. Reported physical symptom frequencies were transformed into continuous scale variables, which were then analysed using one way analysis of variance, general linear modelling and Spearman rank correlations.ResultsThere were 496 participants. Fatigue, insomnia and flatulence were the most frequent symptoms, with ≥20% of respondents reporting these to be often present in the previous week. Eight other symptoms were experienced often by 10–20% of respondents. At least one of these eleven most common symptoms was experienced frequently by almost every respondent (99%). 66% of respondents experienced at least two of these symptoms together, and 16% experienced five or more together. Current stoma was the single most common variable associated with increased symptom scores, although statistically significant relationships (p ≤ 0.05) between symptom frequency scores and clinical/demographic variables were generally weak (R-sq value ≤0.08).ConclusionFindings may inform targeted interventions during the nine month to three year post diagnosis timeframe, which would enable supported self-management of symptoms.Electronic supplementary materialThe online version of this article (10.1186/s12885-018-4923-3) contains supplementary material, which is available to authorized users.

The multiple mediating effects of cancer threat appraisal and quality of life on the association between mindfulness and depression for colorectal cancer survivors

“…Among the colorectal symptoms, flatulence was the most common physical symptoms followed by abdominal pain, bloated feeling, and buttock pain in our study. Similar to the previous studies, 3,30 our work also demonstrates that symptom distress influences cancer survivors' emotional status. Consistent with the review study, 31 there were no correlations of cancer type, cancer stage, or cancer treatments with depression.…”

Clinical Evaluation and Pattern of Symptoms in Colorectal Cancer Patients

“…In general, throughout treatment and for some time after its completion, survivors may experience multiple moderate to severe physical symptoms, including diarrhea, flatulence, changes in the frequency of bowel movement and urination, abdominal pain, nausea and vomiting, and fatigue. Although there is some consensus on time since treatment and the influence of certain factors such as staging, age and metastasis on symptoms in colorectal cancer survivors, there is limited evidence and information on the full extent of colorectal cancer symptoms and survival are fragmented (19) . For this reason, the study of symptoms has gained notoriety in recent years, especially from techniques that seek to qualify the description of its occurrence and intensity (20) .…”

Long term outcome of anastomotic leakage in patients undergoing low anterior resection for rectal cancer

“…Follow-up data was obtained from medical records, outpatient clinic or phone interview. Long-term functional genito-urinary and digestive outcomes as well as quality of life assessments were recorded using a French translation of the low anterior resection score [27], the Wexner continence grading scale [28], the IIEF-5 erectile dysfunction score [29], the SF36 health survey [30], a French validated version of the European Organization for Research and Treatment of Quality of Life Questionnaire for Colorectal Cancer (EORTC QLQ-CR30) [31], the EUROQOL non disease-specific instrument for evaluation healthrelated quality of life [32] and the Fecal Incontinence Quality-of-life (FIQL) scale [33]. All previously mentioned surveys and questionnaires were collected in outpatient clinic or by phone interview whenever possible.…”